{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:06:55Z","timestamp":1789056415237,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005626","name":"Universit\u00e4t Regensburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005626","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omta.2026.201795","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:41:10Z","timestamp":1782319270000},"page":"201795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["AAV-norrin gene therapy rescues retinal defects in mice with Norrie disease and oxygen-induced retinopathy"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8892-2703","authenticated-orcid":false,"given":"Andrea E.","family":"Dillinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Jaegle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Strobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Redemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst R.","family":"Tamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201795_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.preteyeres.2012.02.002","article-title":"Norrin: molecular and functional properties of an angiogenic and neuroprotective growth factor","volume":"31","author":"Ohlmann","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omta.2026.201795_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.exer.2011.06.016","article-title":"Focus on molecules: norrin","volume":"102","author":"Ohlmann","year":"2012","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omta.2026.201795_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cells12212579","article-title":"Mechanisms Underlying Rare Inherited Pediatric Retinal Vascular Diseases: FEVR, Norrie Disease, Persistent Fetal Vascular Syndrome","volume":"12","author":"Le","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.omta.2026.201795_bib4","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0092-8674(04)00216-8","article-title":"Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair","volume":"116","author":"Xu","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201795_bib5","first-page":"2450","article-title":"Retinal vasculature changes in Norrie disease mice","volume":"39","author":"Richter","year":"1998","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2026.201795_bib6","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1167\/iovs.05-0174","article-title":"Role of the Norrie disease pseudoglioma gene in sprouting angiogenesis during development of the retinal vasculature","volume":"46","author":"Luhmann","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2026.201795_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2009.07.047","article-title":"Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization","volume":"139","author":"Ye","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201795_bib8","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1523\/JNEUROSCI.4756-04.2005","article-title":"Ectopic norrin induces growth of ocular capillaries and restores normal retinal angiogenesis in Norrie disease mutant mice","volume":"25","author":"Ohlmann","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omta.2026.201795_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2009.07.048","article-title":"TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4\/beta-catenin signaling","volume":"139","author":"Junge","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201795_bib10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0196-0709(90)90007-I","article-title":"Histopathology of the ears, eyes, and brain in Norrie's disease (oculoacousticocerebral degeneration)","volume":"11","author":"Nadol","year":"1990","journal-title":"Am. J. Otolaryngol."},{"key":"10.1016\/j.omta.2026.201795_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1523\/JNEUROSCI.3210-09.2010","article-title":"Norrin promotes vascular regrowth after oxygen-induced retinal vessel loss and suppresses retinopathy in mice","volume":"30","author":"Ohlmann","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omta.2026.201795_bib12","article-title":"Anti-vascular endothelial growth factor for neovascular age-related macular degeneration","volume":"3","author":"Solomon","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.omta.2026.201795_bib13","first-page":"CD009734","article-title":"Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity","volume":"1","author":"Sankar","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.omta.2026.201795_bib14","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/aos.17541","article-title":"Impact of anti-VEGF therapy versus laser therapy on mortality and treatment outcomes in retinopathy of prematurity: A systematic review and meta-analysis","volume":"104","author":"Wang","year":"2026","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.omta.2026.201795_bib15","doi-asserted-by":"crossref","first-page":"18751","DOI":"10.1073\/pnas.0905010106","article-title":"An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris","volume":"106","author":"Saint-Geniez","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201795_bib16","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1172\/JCI65157","article-title":"Targeted deletion of Vegfa in adult mice induces vision loss","volume":"122","author":"Kurihara","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omta.2026.201795_bib17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41419-026-08963-z","article-title":"VEGFR2 deletion increases susceptibility to photoreceptor degeneration through glial-neuronal interaction","volume":"17","author":"Braunger","year":"2026","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omta.2026.201795_bib18","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202113977","article-title":"A Norrin\/Wnt surrogate antibody stimulates endothelial cell barrier function and rescues retinopathy","volume":"13","author":"Chidiac","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omta.2026.201795_bib19","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202317393","article-title":"Systemic gene therapy rescues retinal dysfunction and hearing loss in a model of Norrie disease","volume":"15","author":"Pauzuolyte","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omta.2026.201795_bib20","article-title":"A Frizzled4-LRP5 agonist promotes blood-retina barrier function by inducing a Norrin-like transcriptional response","volume":"26","author":"Zhang","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.omta.2026.201795_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100827","article-title":"Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives","volume":"77","author":"Garafalo","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omta.2026.201795_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108862","article-title":"Retina-directed gene therapy: Achievements and remaining challenges","volume":"271","author":"Biber","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.omta.2026.201795_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005708","article-title":"In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omta.2026.201795_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007467","article-title":"A novel adeno-associated viral variant for efficient and selective intravitreal transduction of rat Muller cells","volume":"4","author":"Klimczak","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2026.201795_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10633-016-9534-1","article-title":"Differentiation of murine models of \u201cnegative ERG\u201d by single and repetitive light stimuli","volume":"132","author":"Tanimoto","year":"2016","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.omta.2026.201795_bib26","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1172\/JCI76431","article-title":"Canonical WNT signaling components in vascular development and barrier formation","volume":"124","author":"Zhou","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omta.2026.201795_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158320","article-title":"Fzd4 Haploinsufficiency Delays Retinal Revascularization in the Mouse Model of Oxygen Induced Retinopathy","volume":"11","author":"Ngo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2026.201795_bib28","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1161\/ATVBAHA.118.311689","article-title":"Endothelial Cell-Specific Inactivation of TSPAN12 (Tetraspanin 12) Reveals Pathological Consequences of Barrier Defects in an Otherwise Intact Vasculature","volume":"38","author":"Zhang","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.omta.2026.201795_bib29","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1167\/iovs.08-1731","article-title":"Differential gene expression in Ndph-knockout mice in retinal development","volume":"50","author":"Sch\u00e4fer","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2026.201795_bib30","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/hmg\/ddn047","article-title":"A model for familial exudative vitreoretinopathy caused by LPR5 mutations","volume":"17","author":"Xia","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omta.2026.201795_bib31","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/CIRCULATIONAHA.111.040337","article-title":"Wnt signaling mediates pathological vascular growth in proliferative retinopathy","volume":"124","author":"Chen","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.omta.2026.201795_bib32","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/hmg\/dds087","article-title":"Norrin stimulates cell proliferation in the superficial retinal vascular plexus and is pivotal for the recruitment of mural cells","volume":"21","author":"Zuercher","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omta.2026.201795_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.gep.2010.10.007","article-title":"Expression of the Norrie disease gene (Ndp) in developing and adult mouse eye, ear, and brain. Gene Expr","volume":"11","author":"Ye","year":"2011","journal-title":"Patterns"},{"key":"10.1016\/j.omta.2026.201795_bib34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-3-031-27681-1_35","article-title":"Retinal Pigmented Epithelium-Derived Ectopic Norrin Does Not Promote Intraretinal Angiogenesis in Transgenic Mice","volume":"1415","author":"Dillinger","year":"2023","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.omta.2026.201795_bib35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jcp.10128","article-title":"Angiopoietin-2 plays an important role in retinal angiogenesis","volume":"192","author":"Hackett","year":"2002","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.omta.2026.201795_bib36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/1097-4652(200009)184:3<275::AID-JCP1>3.0.CO;2-7","article-title":"Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization","volume":"184","author":"Hackett","year":"2000","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.omta.2026.201795_bib37","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1167\/iovs.06-1306","article-title":"Ocular gene transfer with self-complementary AAV vectors","volume":"48","author":"Yokoi","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2026.201795_bib38","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1074\/jbc.RA119.011273","article-title":"Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability","volume":"295","author":"D\u00edaz-Cor\u00e1nguez","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201795_bib39","article-title":"Wnt signaling activates MFSD2A to suppress vascular endothelial transcytosis and maintain blood-retinal barrier","volume":"6","author":"Wang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omta.2026.201795_bib40","series-title":"Morphogenesis of Endothelium","first-page":"23","article-title":"Endothelial fenestrae and fenestral diaphragms","author":"Roberts","year":"2000"},{"key":"10.1016\/j.omta.2026.201795_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40942-018-0125-z","article-title":"Incidence and risk factors for retinopathy of prematurity: a retrospective cohort study","volume":"4","author":"Freitas","year":"2018","journal-title":"Int. J. Retina Vitreous"},{"key":"10.1016\/j.omta.2026.201795_bib42","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ajo.2010.08.037","article-title":"Vitreous levels of angiopoietin-1 and angiopoietin-2 in eyes with retinopathy of prematurity","volume":"151","author":"Sato","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.omta.2026.201795_bib43","doi-asserted-by":"crossref","first-page":"15732","DOI":"10.1074\/jbc.274.22.15732","article-title":"Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells","volume":"274","author":"Oh","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201795_bib44","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1167\/iovs.02-0276","article-title":"Potential role of the angiopoietin\/tie2 system in ischemia-induced retinal neovascularization","volume":"44","author":"Takagi","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2026.201795_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1192464","article-title":"Delineating effects of angiopoietin-2 inhibition on vascular permeability and inflammation in models of retinal neovascularization and ischemia\/reperfusion","volume":"17","author":"Canonica","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.omta.2026.201795_bib46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1742-2094-8-176","article-title":"Neuroprotective response after photodynamic therapy: role of vascular endothelial growth factor","volume":"8","author":"Suzuki","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.omta.2026.201795_bib47","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1167\/iovs.11-8353","article-title":"Expression and role of VEGF in the adult retinal pigment epithelium","volume":"52","author":"Ford","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2026.201795_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003554","article-title":"Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors","volume":"3","author":"Saint-Geniez","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2026.201795_bib49","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1096\/fj.00-0495fje","article-title":"Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades","volume":"15","author":"Matsuzaki","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.omta.2026.201795_bib50","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/01.wcb.0000037988.07114.98","article-title":"Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism","volume":"22","author":"Svensson","year":"2002","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.omta.2026.201795_bib51","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1165\/rcmb.2014-0338MA","article-title":"Modeling Pulmonary Disease Pathways Using Recombinant Adeno-Associated Virus 6.2","volume":"53","author":"Strobel","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.omta.2026.201795_bib52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/hgtb.2018.228","article-title":"Standardized, Scalable, and Timely Flexible Adeno-Associated Virus Vector Production Using Frozen High-Density HEK-293 Cell Stocks and CELLdiscs","volume":"30","author":"Strobel","year":"2019","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omta.2026.201795_bib53","first-page":"137","article-title":"A formaldehyde-glutaraldehyde fixative of high osmolality for use in electron-microscopy","volume":"27","author":"Karnovsky","year":"1965","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.omta.2026.201795_bib54","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:13:05Z","timestamp":1789053185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26001308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3117387X26001308"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201795","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV-norrin gene therapy rescues retinal defects in mice with Norrie disease and oxygen-induced retinopathy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201795","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201795"}}